Reducing calories may help cognitive function in MS

Published Date: 02 Mar 2023

Multiple sclerosis patients who cut calories two days a week not only lost weight but also experienced better cognition and other benefits in a new study.

Read Full News

Latest News

TBI History Tied to False-Negative Alzheimer’s Blood Test

FDA-approved p-tau217/amyloid-beta-42 testing missed more amyloid PET-positive cases among older adults with prior TBI, a cross-sectional cohort study shows.

p-Tau217 May Predict Cognitive Decline Years Before Symptoms

Higher plasma p-tau217 levels identified cognitively sound older adults at greater risk for future cognitive impairment up to a decade before symptom onset.

ENTF Stim Boosts Freedom From Disability Post-Stroke

Electromagnetic stimulation combined with physical and occupational therapy is linked to a higher rate of freedom from disability post-stroke than sham, a study shows.

Rituximab Noninferior to Ocrelizumab in Relapsing MS

Rituximab is noninferior to ocrelizumab in suppressing disease activity in newly diagnosed multiple sclerosis, with a similar incidence of adverse events, a new trial shows.

FDA Neurology Roundup: June 2026

A monthly snapshot of FDA activity involving therapies for the prevention and treatment of neurologic diseases.

AI Uncovers ‘Invisible’ Cortical Lesions in MS MRI Scans

AI-enhanced analysis of conventional MRI scans reveals thousands of hidden cortical lesions in multiple sclerosis, potentially opening a new window into disease progression.

Todays Updates

In SCLC, Radiotherapy Plus Immunotherapy Ups Fatal Events

A lung cancer trial was stopped early due to a high rate of fatal adverse events with the addition of thoracic radiotherapy to standard maintenance immunotherapy.

Smoldering Myeloma: The Treatment Issue Is Getting Trickier

An FDA approval, striking CAR T data, and a field that can't agree on what to do next. Experts weigh in on the most contentious question in myeloma.

Todays Updates

In SCLC, Radiotherapy Plus Immunotherapy Ups Fatal Events

A lung cancer trial was stopped early due to a high rate of fatal adverse events with the addition of thoracic radiotherapy to standard maintenance immunotherapy.

Smoldering Myeloma: The Treatment Issue Is Getting Trickier

An FDA approval, striking CAR T data, and a field that can't agree on what to do next. Experts weigh in on the most contentious question in myeloma.

Latest News

FDA-approved p-tau217/amyloid-beta-42 testing missed more amyloid PET-positive cases among older adults with prior TBI, a cross-sectional cohort study shows.

Higher plasma p-tau217 levels identified cognitively sound older adults at greater risk for future cognitive impairment up to a decade before symptom onset.

Electromagnetic stimulation combined with physical and occupational therapy is linked to a higher rate of freedom from disability post-stroke than sham, a study shows.

Rituximab is noninferior to ocrelizumab in suppressing disease activity in newly diagnosed multiple sclerosis, with a similar incidence of adverse events, a new trial shows.

A monthly snapshot of FDA activity involving therapies for the prevention and treatment of neurologic diseases.

AI-enhanced analysis of conventional MRI scans reveals thousands of hidden cortical lesions in multiple sclerosis, potentially opening a new window into disease progression.

News All Time

RFK Jr. Seeks to Peek at Americans' Medical Records for Clues on Autism and Vaccines

Some public health leaders have raised doubts that giving access would be legal or even useful

MAHA's Autism Treatments: Camel's Milk, Stem Cell Injections, and Spelling Therapy

Experts say some of the methods may be fraudulent

Primitive Reflexes May Predict Dementia

Two or more frontal release signs in cognitively normal people tied to higher risk of dementia

Brain Institute Halts Research; Parkinson's Deaths Fall; Meet the 'Dementia Rebels'

News and commentary from the world of neurology and neuroscience

Alzheimer's May Be Worse for People Taking Popular Supplement

Glucosamine tied to faster progression in people with established neurodegeneration

Genetic Risk of Autism, ADHD Decreased as Diagnoses Increased

Study offers "new perspective for ongoing debates" about increasing diagnoses, researchers say

Report: Law Firms Cheated in Filing Claims With NFL's Concussion Settlement Fund

The fund was meant to last for 65 years

Ebola's Brain Effects Persist More Than 7 Years After Infection

Many survivors still had neurologic symptoms, most notably memory loss

Alzheimer's and Psilocybin; Migraine and Driving; What New MS Criteria Reveal

News and commentary from the world of neurology and neuroscience

Hospital's Brain Tumor Cluster; Princess's Lung Transplant; Plastic Surgery Deaths

Health news and commentary gathered by MedPage Today staff

Brain Disorders and TBI May Fuel Each Other

Two-way relationships with traumatic brain injury emerge in a large study of veterans

FDA Reverses Course on Neuro Drugs; Omega-3s and Dementia; Brain Death Test Lawsuit

News and commentary from the world of neurology and neuroscience

ALS Testing Expected to Drive Sharp Rise in Clinic Visits

Genetic screening in the wake of new therapies will identify more at-risk relatives

First State Bans Paraquat, a Weed Killer Linked to Parkinson's Disease

The herbicide is used widely in the U.S. but banned in China and Europe

Study Suggests No Link Between Prenatal Tylenol and Risks for Autism, ADHD

Research shows the power of negative control analyses

NFL Star Diagnosed With ALS at 39; 'No Surprises' Windfall; Arizona Plague Scare

Health news and commentary gathered by MedPage Today staff

Recommended News For You

"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.

PSA Screening May Modestly Curb Prostate Cancer Deaths

Congresswoman has cancer; the IRS is suing a controversial doctor; and caffeine and teenagers.

Eltrombopag Improves Outcomes in Kids With Newly Diagnosed ITP

the contribution of cortactin to the development of cancer.

Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?

Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival

Recommended Articles For You

Symptoms and Causes of Phlegmasia Cerulea Dolens: A Comprehensive Guide  

Revolutionizing Lung Transplantation: The Promise of Donor-Specific Blood Transfusion 

Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care 

Cardiotoxicity Beyond Anthracyclines: Redefining Risk in the Cardio-Oncology Era 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Prostate cancer detection with PET CT and PET MRI is comparable.

2.

Prostate Cancer Treatment Associated With Long-Term Complications

3.

Prostate cancer relapse after radiotherapy is strongly predicted by biological markers.

4.

Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials

5.

Snus Linked to Gingival Damage, Raising Safety Questions

1.

Effective Management Strategies for Sickle Cell Crisis: Insights from Medical Experts

2.

Revolutionizing Lung Transplantation: The Promise of Donor-Specific Blood Transfusion

3.

Unlocking the Benefits of Eltrombopag: A Comprehensive Guide

4.

Strategic Applications in Hematology in Clinical Decision-Making

5.

Case Study: The Role of JAK Inhibitors in Myeloproliferative Disorders

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V

3.

Should We Use DARA Up Front As First-Line Therapy in MM?

4.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot